Clinical trial
The SMS Study, a National Study on Prevalence of Unexplained Splenomegaly Etiologies
NCT04430881 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The SMS Study, a National Study on Prevalence of Unexplained Splenomegaly Etiologies
- Lead sponsor
- Sanofi
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 30, 2015
- Completion date
- April 27, 2021
- Enrollment
- 506 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.